Ventricular tachyarrhythmia treatment and prevention by subthreshold stimulation with stretchable epicardial multichannel electrode array.
Sung-Hyuk SunwooMyung Jin ChaSang Ihn HanHyejeong KangYe Seul ChoDa-Hae YeomChan Soon ParkNa Kyeong ParkSeong Woo ChoiSung Joon KimDae-Hyeong KimDongjun JungSuji ChoiSeil OhGi-Byoung NamTaeghwan HyeonDae-Hyeong KimSeung-Pyo LeePublished in: Science advances (2023)
The implantable cardioverter-defibrillator (ICD) is an effective method to prevent sudden cardiac death in high-risk patients. However, the transvenous lead is incompatible with large-area electrophysiological mapping and cannot accommodate selective multichannel precision stimulations. Moreover, it involves high-energy shocks, resulting in pain, myocardial damage, and recurrences of ventricular tachyarrhythmia (VTA). We present a method for VTA treatment based on subthreshold electrical stimulations using a stretchable epicardial multichannel electrode array, which does not disturb the normal contraction or electrical propagation of the ventricle. In rabbit models with myocardial infarction, the infarction was detected by mapping intracardiac electrograms with the stretchable epicardial multichannel electrode array. Then, VTAs could be terminated by sequential electrical stimuli from the epicardial multichannel electrode array beginning with low-energy subthreshold stimulations. Last, we used these subthreshold stimulations to prevent the occurrence of additional VTAs. The proposed protocol using the stretchable epicardial multichannel electrode array provides opportunities toward the development of innovative methods for painless ICD therapy.
Keyphrases
- high resolution
- high density
- high throughput
- left ventricular
- heart failure
- carbon nanotubes
- risk assessment
- randomized controlled trial
- newly diagnosed
- chronic pain
- oxidative stress
- solid state
- end stage renal disease
- mesenchymal stem cells
- ejection fraction
- bone marrow
- chronic kidney disease
- patient reported outcomes
- prognostic factors
- mitral valve